Compounds > glutathionyldopa
Page last updated: 2024-09-03

glutathionyldopa and 5-(3,3-dimethyl-1-triazeno)-1-methylimidazole-4-carboxamide

glutathionyldopa has been researched along with 5-(3,3-dimethyl-1-triazeno)-1-methylimidazole-4-carboxamide in 1 studies

Compound Research Comparison

Studies
(glutathionyldopa)		Trials
(glutathionyldopa)		Recent Studies (post-2010)
(glutathionyldopa)		Studies
(5-(3,3-dimethyl-1-triazeno)-1-methylimidazole-4-carboxamide)		Trials
(5-(3,3-dimethyl-1-triazeno)-1-methylimidazole-4-carboxamide)		Recent Studies (post-2010) (5-(3,3-dimethyl-1-triazeno)-1-methylimidazole-4-carboxamide)
1001920

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ichihashi, M; Inoi, T; Mishima, Y; Mojamdar, M1

Other Studies

1 other study(ies) available for glutathionyldopa and 5-(3,3-dimethyl-1-triazeno)-1-methylimidazole-4-carboxamide

ArticleYear
[Therapeutic evaluation of human malignant melanoma by urinary 5-S-cysteinyldopa dynamics: chemotherapy and surgery].
    Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology, 1984, Volume: 94, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Cysteinyldopa; Dacarbazine; Dihydroxyphenylalanine; Female; Humans; Immunotherapy; Male; Melanoma; Middle Aged; Nimustine; Nitrosourea Compounds; Prognosis; Vincristine

1984